PRCT · Procept BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Market Cap
1.03B
52 Wk Range
$16.66 - $38.11
Previous Close
$18.43
Open
$18.34
Volume
914,635
Day Range
$17.95 - $18.62
Enterprise Value
905.1M
Cash
227.9M
Avg Qtr Burn
-19.25M
Insider Ownership
3.48%
Institutional Own.
N/A
Qtr Updated
Jun 30th 2026
